Document is current
Any future updates will be listed below
-
Authors
Lowe, Michael https://orcid.org/0000-0001-5712-3800
Berman, Gabriele https://orcid.org/0009-0008-3390-9508
Thaller, Mark https://orcid.org/0000-0001-7772-2157
Mollan, Susan P. https://orcid.org/0000-0002-6314-4437
- License Information
-
More Information
Article History
Received: 9 June 2025
Revised: 11 June 2025
Accepted: 26 June 2025
First Online: 4 July 2025
Competing interests
: SM reports consultancy fees (Invex Therapeutics), advisory board fees (Ocular Therapeutix), speaker fees (Teva), travel (AbbVie and European Alliance of Associations for Rheumatology), and receipt of equipment (Heidelberg Engineering). SM is a section editor at Eye Journal. ML reports speaker fees (Pfizer) and travel (AbbVie, Teva, Lundbeck). Authors declare no other financial relationships with any organisations that might have an interest in the submitted work, and no other relationships or activities that could appear to have influenced the submitted work.
